2021 annual financial data
Xilio Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -75,044,000 USD and net income was -74,301,000 USD.
Operating cash flow was -80,751,000 USD.
Get free Xilio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -75,044,000 USD
- Net income
- -74,301,000 USD
- Operating cash flow
- -80,751,000 USD